Scarcity of medicine

Kumar Prithwiraj Nath, Toronto, Canada
The scarcity of medicine in the country, as observed in the last few days, appears to be very artificial and the result of the manipulation of pharmaceutical companies. Bangladesh has earned its reputation for production of quality medicines and the pharmaceutical companies have demonstrated their excellence at home and abroad. Unfortunately, the profit-earning tendency of these companies does not deserve any appreciation when we observe that the MRP increases every year almost on all products, especially on life saving drugs. Their tendency to manipulate the market by creating artificial crisis and disruption in the distribution network are major reasons for price hike as well as short supply of medicines. At least 56 companies are exporting drugs and medicines abroad and obtaining all facilities from the government. The Ministry of Health and the Directorate of Drug Administration should come up with close monitoring of the distribution network and formulate stringent regulations on pricing and distribution. The management of essential drugs should be strengthened to provide services in case of emergency and overcome any short supply in the market.